Zepbound-Associated Muscle Mass Loss
Evidence for Muscle Loss with GLP-1 Receptor Agonists
- The American Diabetes Association guidelines state that weight management pharmacotherapy, including GLP-1 receptor agonists like tirzepatide, can lead to decreased body weight that induces fat mass loss as well as loss of lean body mass, raising concerns about muscle mass loss leading to frailty and sarcopenic obesity in older adults 1
- Loss of muscle mass during weight loss is a recognized complication that occurs alongside fat loss when using GLP-1 receptor agonists, contributing to sarcopenic obesity and increased frailty over time 1
- Similar concerns exist with glucagon-like peptide-1 receptor agonists used in patients, where loss of muscle mass is a particular concern in older people at risk for sarcopenia 2
Mitigation Strategy: Resistance Exercise is Essential
- The American Diabetes Association strongly recommends that patients taking weight loss medications like Zepbound engage in muscle-strengthening activities to reduce the loss of lean mass 1
- Resistance exercise training 2-3 sessions per week on nonconsecutive days is recommended for all adults with diabetes or obesity taking weight management pharmacotherapy to improve strength, balance, and ability to engage in activities of daily living 1
- Heavier resistance training with free weights or weight machines may provide additional benefits for glycemia and strength 1
Clinical Monitoring Recommendations
- Document weight and body mass index every 6 months for individuals on GLP-1 receptor agonist therapy to identify excessive weight loss or muscle loss 2
- Consider body composition assessment to differentiate fat loss from muscle loss, particularly in older adults or those at risk for sarcopenia 3
- Monitor for functional decline, weakness, or reduced ability to perform activities of daily living that may indicate significant muscle loss 1
Nutritional Support to Preserve Muscle
- Protein intake should target adequate levels to support muscle protein synthesis during periods of weight loss 4
- Nutritional counseling should accompany pharmacotherapy to optimize body composition outcomes 1